Regeneron Pharmaceuticals (REGN)
EV/EBITDA
14.34×
TTM · Retrieved:
REGN EV/EBITDA
Current (TTM)14.34×retrieved
Current (TTM)14.34×retrieved
REGN Quarterly EV/EBITDA (0.00× → 38.50×)
Latest values, visible window
High-resolution chart · PNG
REGN ev/ebitda history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EV/EBITDA |
|---|---|
| 38.4991× | |
| 82.8059× | |
| 65.795× | |
| 30.4597× | |
| 33.7196× | |
| 64.6617× | |
| 70.3896× | |
| 70.2065× | |
| 65.234× | |
| 125.8791× | |
| 73.1868× | |
| 71.3379× | |
| 64.4442× | |
| 88.966× | |
| 53.2485× | |
| 47.5455× | |
| 63.4762× | |
| 68.1657× | |
| 25.8031× | |
| 33.3699× | |
| 15.4423× | |
| 40.1054× | |
| 39.5218× | |
| 55.5204× | |
| 69.4508× | |
| 74.8137× | |
| 44.1875× | |
| 37.3938× | |
| 126.2064× | |
| 76.657× | |
| 57.9598× | |
| 66.2456× | |
| 56.3485× | |
| 62.484× | |
| 72.9965× | |
| 85.6542× | |
| 100.5934× | |
| 93.1159× | |
| 114.5989× | |
| 117.4882× | |
| 127.1485× | |
| 116.1493× | |
| 245.1484× | |
| 129.8326× | |
| 163.1258× | |
| 172.4668× | |
| 203.0102× | |
| 207.7795× | |
| 135.2714× | |
| 170.6254× | |
| 138.5629× | |
| 143.6354× | |
| 151.3738× | |
| 121.5731× | |
| 122.6726× | |
| 82.7289× | |
| 113.7443× | |
| 350.4634× | |
| -137.4191× | |
| -106.1918× | |
| -97.9141× | |
| -122.2992× | |
| -638.4251× | |
| -77.4147× | |
| -94.2153× | |
| -90.2806× | |
| -54.2367× | |
| 588.8055× | |
| -91.8267× | |
| -49.4465× | |
| -47.2213× | |
| -88.9441× | |
| -57.7283× | |
| -91.4312× | |
| -185.1735× | |
| -36.9437× | |
| -45.8774× | |
| -47.4439× | |
| -42.4717× | |
| -37.7547× | |
| -39.6269× | |
| -53.7945× | |
| 4.0652× | |
| -18.2299× | |
| -18.4904× | |
| -13.7815× | |
| 77.3521× | |
| -82.1104× | |
| -66.3602× | |
| 32.6431× | |
| -70.5297× | |
| -38.1799× | |
| -31.8078× | |
| -13.0871× | |
| -28.7434× | |
| -23.9266× | |
| -26.7837× | |
| -50.8274× | |
| -42.56× | |
| -40.717× |